If you do not want to get become pregnant again, start using a birth control method of your choice as soon as your pregnancy ends. FDA does not endorse or promote any drug product. The agency evaluates all drug applications submitted by sponsors to determine whether a drug is safe and effective for its proposed indication under the conditions of use in the labeling. This means that the benefits of the drug outweigh its risks. The same standards were applied to the new drug application for mifepristone as are applied to all applications.
Manufacturers establish prices for prescription drugs.
FDA has no input into or jurisdiction over drug pricing. FDA does not know what mifepristone will cost when it becomes available. The FDA has no input into or legal control over whether an insurance company does or does not cover the cost of a drug. Insurance coverage is a decision made by your insurance provider. Please call your insurance company if you have questions, about whether your particular insurance provider will cover the cost of mifepristone.